Benefit-risk balance of hormone replacement therapy: Cancers and mortality. Postmenopausal women management- CNGOF and GEMVi clinical practice guidelines

被引：2

作者：

Poudou, C. ^{[1
]}

Baffet, H. ^{[2
,3
]}

Nadeau, C. ^{[1
]}

Rolland, A-L ^{[2
,3
]}

Catteau-Jonard, S. ^{[2
,4
]}

Robin, G. ^{[2
,4
]}

机构：

[1] CHU Poitiers, Serv Gynecol Obstet & Med Reprod, 2 Rue Miletrie, F-86021 Poitiers, France

[2] CHU Lille, Serv Gynecol Med Orthogenie & Sexol, Hop Jeanne de Flandre, Ave Eugene Avinee, F-59073 Lille, France

[3] CHU Lille, Serv Assistance Med Procreat & Preservat Fertilit, Ave Eugene Avinee, F-59037 Lille, France

[4] Univ Lille, Fac Med, 2 Ave Eugene Avinee, F-59120 Loos, France

来源：

GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE | 2021年 / 49卷 / 05期

关键词：

Hormone replacement therapy (HRT); Breast cancer; Colorectal cancer; Endometrial cancer; Ovarian cancer; Mortality; ESTROGEN PLUS PROGESTIN; ENDOMETRIAL CANCER; OVARIAN-CANCER; REPRODUCTIVE FACTORS; ESOPHAGEAL CANCER; COLORECTAL-CANCER; BREAST-CANCER; HEALTH; COHORT; INTERVENTION;

D O I：

10.1016/j.gofs.2021.03.031

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The use of hormone replacement therapy (HRT) for menopausal women has been the subject of much controversy in recent years, particularly concerning the carcinologic risks. The purpose of this review is to evaluate the impact of the use of HRT on the risk of gynecological but also extra-gynecological cancers. The effect of the type and the duration of use of HRT in menopausal women will also be discussed. The beneficial impact of HRT on overall mortality is also an element that will be discussed and must be taken into account when evaluating the benefit-risk balance of HRT for menopausal women. (c) 2021 Elsevier Masson SAS. All rights reserved.

引用

页码：462 / 473

页数：12

共 52 条

[1] Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition
Allen, Naomi E.
Tsilidis, Konstantinos K.
Key, Timothy J.
Dossus, Laure
Kaaks, Rudolf
Lund, Eiliv
Bakken, Kjersti
Gavrilyuk, Oxana
Overvad, Kim
Tjonneland, Anne
Olsen, Anja
Fournier, Agnes
Fabre, Alban
Clavel-Chapelon, Francoise
Chabbert-Buffet, Nathalie
Sacerdote, Carlotta
Krogh, Vittorio
Bendinelli, Benedetta
Tumino, Rosario
Panico, Salvatore
Bergmann, Manuela
Schuetze, Madlen
van Duijnhoven, Fraenzel J. B.
Bueno-de-Mesquita, H. Bas
Onland-Moret, N. Charlotte
van Gils, Carla H.
Amiano, Pilar
Barricarte, Aurelio
Chirlaque, Maria-Dolores
Molina-Montes, Maria-Esther
Redondo, Maria-Luisa
Duell, Eric J.
Khaw, Kay-Tee
Wareham, Nick
Rinaldi, Sabina
Fedirko, Veronika
Mouw, Traci
Michaud, Dominique S.
Riboli, Elio
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 172 (12) : 1394 - 1403
[2] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
Anderson, GL
Limacher, M
Assaf, AR
Bassford, T
Beresford, SAA
Black, H
Bonds, D
Brunner, R
Brzyski, R
Caan, B
Chlebowski, R
Curb, D
Gass, M
Hays, J
Heiss, G
Hendrix, S
Howard, BV
Hsia, J
Hubbell, A
Jackson, R
Johnson, KC
Judd, H
Kotchen, JM
Kuller, L
LaCroix, AZ
Lane, D
Langer, RD
Lasser, N
Lewis, CE
Manson, J
Margolis, K
Ockene, J
O'Sullivan, MJ
Phillips, L
Prentice, RL
Ritenbaugh, C
Robbins, J
Rossouw, JE
Sarto, G
Stefanick, ML
Van Horn, L
Wactawski-Wende, J
Wallace, R
Wassertheil-Smoller, S
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
[3] [Anonymous], 2015, LANCET
[4] Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition
Bakken, Kjersti
Fournier, Agnes
Lund, Eiliv
Waaseth, Marit
Dumeaux, Vanessa
Clavel-Chapelon, Francoise
Fabre, Alban
Hemon, Bertrand
Rinaldi, Sabina
Chajes, Veronique
Slimani, Nadia
Allen, Naomi E.
Reeves, Gillian K.
Bingham, Sheila
Khaw, Kay-Tee
Olsen, Anja
Tjonneland, Anne
Rodriguez, Laudina
Sanchez, Maria-Jose
Amiano Etxezarreta, Pilar
Ardanaz, Eva
Tormo, Maria-Jose
Peeters, Petra H.
van Gils, Carla H.
Steffen, Annika
Schulz, Mandy
Chang-Claude, Jenny
Kaaks, Rudolf
Tumino, Rosario
Gallo, Valentina
Norat, Teresa
Riboli, Elio
Panico, Salvatore
Masala, Giovanna
Gonzalez, Carlos A.
Berrino, Franco
[J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (01) : 144 - 156
[5] Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis
Benkhadra, Khalid
Mohammed, Khaled
Al Nofal, Alaa
Leon, Barbara G. Carranza
Alahdab, Fares
Faubion, Stephanie
Montori, Victor M.
Abu Dabrh, Abd Moain
Hernandez, Jorge Alberto Zuniga
Prokop, Larry J.
Murad, Mohammad Hassan
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11) : 4021 - 4028
[6] Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0
[7] Beral Valerie, 2003, Lancet, V362, P419
[8] Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
Beresford, SAA
Weiss, NS
Voigt, LF
McKnight, B
[J]. LANCET, 1997, 349 (9050) : 458 - 461
[9] Hormone therapy for preventing cardiovascular disease in post-menopausal women
Boardman, Henry M. P.
Hartley, Louise
Eisinga, Anne
Main, Caroline
Roque i Figuls, Marta
Bonfill Cosp, Xavier
Gabriel Sanchez, Rafael
Knight, Beatrice
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):
[10] Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
Botteri, Edoardo
Stoer, Nathalie C.
Sakshaug, Solveig
Graff-Iversen, Sidsel
Vangen, Siri
Hofvind, Solveig
de lange, Thomas
Bagnardi, Vincenzo
Ursin, Giske
Weiderpass, Elisabete
[J]. BMJ OPEN, 2017, 7 (11):

← 1 2 3 4 5 6 →